Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer HO Lee, Y Hong, HE Etlioglu, YB Cho, V Pomella, B Van den Bosch, ... Nature genetics 52 (6), 594-603, 2020 | 537 | 2020 |
Determinants of response and intrinsic resistance to PD-1 blockade in microsatellite instability–high gastric cancer M Kwon, M An, SJ Klempner, H Lee, KM Kim, JK Sa, HJ Cho, JY Hong, ... Cancer discovery 11 (9), 2168-2185, 2021 | 174 | 2021 |
Early tumor–immune microenvironmental remodeling and response to first-line fluoropyrimidine and platinum chemotherapy in advanced gastric cancer R Kim, M An, H Lee, A Mehta, YJ Heo, KM Kim, SY Lee, J Moon, ST Kim, ... Cancer discovery 12 (4), 984-1001, 2022 | 109 | 2022 |
TNFα induces LGR5+ stem cell dysfunction in patients with Crohn’s disease C Lee, M An, JG Joung, WY Park, DK Chang, YH Kim, SN Hong Cellular and Molecular Gastroenterology and Hepatology 13 (3), 789-808, 2022 | 31 | 2022 |
Determinants of response and intrinsic resistance to PD-1 blockade in microsatellite instability-high gastric cancer. Cancer Discov. 2021 doi: 10.1158/2159-8290 M Kwon, M An, SJ Klempner, H Lee, KM Kim, JK Sa, HJ Cho, JY Hong, ... CD-21-0219.[Abstract][CrossRef][Academic Search], 0 | 31 | |
Comparison of cell type distribution between single-cell and single-nucleus RNA sequencing: enrichment of adherent cell types in single-nucleus RNA sequencing JM Oh, M An, DS Son, J Choi, YB Cho, CE Yoo, WY Park Experimental & Molecular Medicine 54 (12), 2128-2134, 2022 | 20 | 2022 |
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer M An, A Mehta, BH Min, YJ Heo, SJ Wright, M Parikh, L Bi, H Lee, TJ Kim, ... Cancer Discovery 14 (5), 766-785, 2024 | 15 | 2024 |
An adaptive detection method for fetal chromosomal aneuploidy using cell-free DNA from 447 Korean women S Kim, HJ Jung, SH Han, SJ Lee, JS Kwon, MG Kim, H Chu, K Han, ... BMC medical genomics 9, 1-8, 2016 | 11 | 2016 |
Sequential pembrolizumab cooperates with platinum/5FU to remodel the tumor microenvironment in advanced gastric cancer: a phase II chemoimmunotherapy trial M An, A Mehta, BH Min, YJ Heo, M Parikh, L Bi, R Cristescu, H Lee, T Kim, ... medRxiv, 2023.04. 03.23288062, 2023 | 2 | 2023 |
Sequential pembrolizumab cooperates with platinum/5FU to remodel the tumor immune microenvironment in advanced gastric cancer: a phase II chemoimmunotherapy trial S Klempner, J Lee, A Mehta, M An, BH Min, YJ Heo, M Parikh, L Bi, ... | 1 | 2023 |
Three-dimensional tumor angiogenesis mapping in metastatic gastric cancer patients J Ko, S Hyung, M An, NL Jeon, J Lee Cancer Research 82 (12_Supplement), 3206-3206, 2022 | 1 | 2022 |
Comprehensive landscape of tumor angiogenesis via integrating RNA sequencing and three-dimensional microphysiological system. J Ko, S Hyung, M An, SH Park, ST Kim, WK Kang, NL Jeon, J Lee Journal of Clinical Oncology 40 (16_suppl), e16058-e16058, 2022 | 1 | 2022 |
Comprehensive molecular characterization to predict immunotherapy response in advanced biliary tract cancer: a phase II trial of pembrolizumab R Kim, JK Park, M Kwon, M An, JY Hong, JO Park, SH Lim, ST Kim Oncology Research 33 (1), 57, 2024 | | 2024 |
Abstract A010: Tumor-reactive T cell clonal dynamics across treatment time points drive resistance and progression to frontline chemoimmunotherapy in advanced gastric cancer SJ Wright, M An, BH Min, YJ Heo, M Parikh, L Bi, H Lee, T Kim, SY Lee, ... Cancer Immunology Research 12 (10_Supplement), A010-A010, 2024 | | 2024 |
Tumor cell metaplastic programs and failure of T cell remodeling drive resistance and progression to frontline chemoimmunotherapy in advanced gastric cancer SJ Wright, M An, BH Min, YJ Heo, M Parikh, L Bi, H Lee, T Kim, SY Lee, ... Cancer Research 84 (6_Supplement), 6846-6846, 2024 | | 2024 |
Method of detecting fetal chromosomal aneuploidy SS Kim, MJ Jeong, KT Min, MA AN, JS HA, SR Lee, JH Bae, HJ Joo US Patent App. 18/225,618, 2023 | | 2023 |
Method of detecting fetal chromosomal aneuploidy SS Kim, MJ Jeong, KT Min, MA AN, JS Ha, SR Lee, JH Bae, HJ Joo US Patent 11,710,565, 2023 | | 2023 |